Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to ...

In a lean biotech environment with aggressive milestones, teams often accept reporting that is “good enough.” But those ...

AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Phase 3 trial results show enlicitide, a once-daily oral PCSK9 inhibitor, cut LDL cholesterol by about 60% in high-risk ...

FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...

As the frozen precipitation is continuing to thaw across the upper part of Mississippi, the Mississippi legislature continues to forge ahead in ...

Treatment with a high-dose regimen of Spinraza safely improved motor function in children with SMA, according to data from ...

Sovereign bio-intelligence company plans to expand clinical trials across Middle East ...

Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...

New research shows MDMA and psilocybin may restore neural flexibility in people with PTSD, thereby helping the brain unlearn ...